VAL CHUM LTD PARTNERSHIP has a total of 11 patent applications. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PROTAGEN AG, FUNDACIÓ HOSPITAL UNI VALL D HEBRON INST DE RECERCA and ZOLLER MARK.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | United States | 3 | |
#3 | Canada | 2 | |
#4 | Australia | 1 | |
#5 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Computer technology | |
#5 | Medical technology | |
#6 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Prentki Marc | 3 |
#2 | Prat Alexandre | 3 |
#3 | Cayrol Romain | 2 |
#4 | Brassard Nathalie | 2 |
#5 | Joly Erik | 2 |
#6 | Arbour Nathalie | 2 |
#7 | Madiraju Murthy | 2 |
#8 | Kebir Hania | 1 |
#9 | Zhao Shangang | 1 |
#10 | Cloutier Guy | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016095046A1 | Dicam-specific antibodies and uses thereof | |
WO2015168786A1 | Method for decreasing retinal ganglion cells degeneration | |
US2015218266A1 | Inhibition of th17 cells migration to inflamed tissues using antibodies directed against mcam | |
WO2015127559A1 | Abhd6 antagonists for promoting browning of white adipose tissue and brown adipose tissue functionality | |
WO2014201571A1 | Heart phantom assembly | |
CA2834108A1 | Screening assays based on mag and/or abhd6 for selecting insulin secretion promoting agents | |
EP2545378A1 | Anti-lg3 antibodies and uses thereof | |
AU2009212789A1 | Ninjurin-1 and/or MCAM Modulation and Uses Thereof |